Details for New Drug Application (NDA): 085853
✉ Email this page to a colleague
NDA 085853 describes A-METHAPRED, which is a drug marketed by Abbott, Hospira, and Hospira Inc, and is included in fourteen NDAs. Additional details are available on the A-METHAPRED profile page.
The generic ingredient in A-METHAPRED is methylprednisolone sodium succinate. There are forty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methylprednisolone sodium succinate profile page.
The generic ingredient in A-METHAPRED is methylprednisolone sodium succinate. There are forty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the methylprednisolone sodium succinate profile page.
Summary for 085853
| Tradename: | A-METHAPRED |
| Applicant: | Hospira |
| Ingredient: | methylprednisolone sodium succinate |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | EQ 40MG BASE/VIAL | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
